If you take a GLP-1 medication, you have probably seen pancreatitis listed somewhere in the paperwork. That line can make your stomach drop, especially if you've had a bad day of nausea. This post is about what happens after the warning label: how doctors check for pancreatitis, who starts with a higher baseline risk, and what the decision about restarting the medication usually looks like. It isn't a substitute for talking with your prescriber, but it can help you walk into that conversation with better questions.
How doctors diagnose pancreatitis linked to GLP-1 medications, who starts with higher baseline risk, and what happens after a suspected episode, including whether to restart.
Why pancreatitis shows up on GLP-1 labels
Acute pancreatitis appears in the Warnings and Precautions section of the prescribing information for semaglutide (Ozempic and Wegovy), liraglutide (Victoza and Saxenda), and tirzepatide (Mounjaro and Zepbound). The wording is not identical from one product to another, so the most reliable move is to read the current label on DailyMed or the FDA website and compare it with what you were told in the clinic.
The link between these drugs and pancreatitis is an observed association. Scientists still debate whether the medication directly causes inflammation of the pancreas, whether the conditions that lead people to start these drugs play a role, or whether both are involved. In most of the studies published so far, the absolute risk appears to be low. Low is not zero, though, and that distinction matters when you're the one dealing with severe belly pain.
Log symptoms with intensity and tie them to each dose to spot patterns.
Track it in the appWho starts with a higher baseline risk
Some people carry risk before the first injection. Very high triglyceride levels are a well-known cause of pancreatitis regardless of which medication someone takes, so a lipid panel before starting is a reasonable thing to ask about. Gallstones and a previous episode of pancreatitis also matter, and the labels usually list gallbladder disease as a separate warning. Heavy alcohol use and kidney disease show up in general pancreatitis guidance as factors that raise risk. If you already keep your lab results in the PeptPro app, bring them to the first visit so your baseline is clear from day one.
Your doctor may order a triglyceride test before you begin and again if you develop new symptoms. The exact threshold for concern and the need for testing depend on your full history, so treat any number on a lab report as a conversation starter rather than a verdict.